Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001116502-10-000064
Filing Date
2010-01-19
Accepted
2010-01-19 10:09:45
Documents
10
Period of Report
2009-09-30

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ohrp_10k.htm 10-K/A 461055
2 ohrp_10k002.gif GRAPHIC 165367
3 ohrp_10k004.gif GRAPHIC 38913
4 ohrp_10k006.gif GRAPHIC 135349
5 ohrp_10k008.gif GRAPHIC 81226
6 CERTIFICATION ohrp_ex311.htm EX-31.1 7065
7 CERTIFICATION ohrp_ex312.htm EX-31.2 7103
8 CERTIFICATION ohrp_ex321.htm EX-32.2 3785
9 CERTIFICATION ohrp_ex322.htm EX-32.1 3282
10 PRESS RELEASE ohrp_ex991.htm EX-99.1 6783
  Complete submission text file 0001116502-10-000064.txt   1071104
Mailing Address 1245 BRICKYARD RD #590 SALT LAKE CITY, UT 84106
Business Address 1245 BRICKYARD RD #590 SALT LAKE CITY, UT 84106 347-753-4389
Ohr Pharmaceutical Inc (Filer) CIK: 0001173281 (see all company filings)

EIN.: 043648721 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K/A | Act: 34 | File No.: 333-88480 | Film No.: 10532154
SIC: 3669 Communications Equipment, NEC